Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
15.06
-0.01 (-0.07%)
At close: May 23, 2025, 3:59 PM
15.01
-0.33%
After-hours: May 23, 2025, 04:20 PM EDT
Spyre Therapeutics Revenue
Spyre Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Spyre Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
73
Market Cap
908.93M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|